Insider · CIK 0002018299
Boxer Capital Management, LLC
Files at TNGX (Tango Therapeutics, Inc.), TYRA (Tyra Biosciences, Inc.). First filing Oct 23, 2024, latest Nov 7, 2024.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
TNGX: Tango Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 51Moderate | Tango Therapeutics, Inc. | $9.7M 3,080,000 shares | -46% | - | |
| 41Moderate | Tango Therapeutics, Inc. | $4.3M 633,000 shares | -9% | - | |
| 38Weak | TNGXsell Tango Therapeutics, Inc. | $6.1M 875,000 shares | -11% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 6, 2024 | TNGX Tango Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See footnote | -3,080,000 | $3.14 | $9.7M | 3,610,642 | Nov 7, 2024 |
| Oct 25, 2024 | TNGX Tango Therapeutics, Inc. | SOpen-market sale Common Stock | -633,000 | $6.87 | $4.3M | 6,690,642 | Oct 28, 2024 |
| Oct 21, 2024 | TNGX Tango Therapeutics, Inc. | SOpen-market sale Common Stock | -625,000 | $7.05 | $4.4M | 7,573,642 | Oct 23, 2024 |
| Oct 22, 2024 | TNGX Tango Therapeutics, Inc. | SOpen-market sale Common Stock | -250,000 | $6.78 | $1.7M | 7,323,642 | Oct 23, 2024 |
| Oct 18, 2024 | TYRA Tyra Biosciences, Inc. | DDisposition to issuer Common Stockindirect: See footnote | -2,000,000 | - | - | 4,448,359 | Oct 22, 2024 |
| Oct 18, 2024 | TYRA Tyra Biosciences, Inc. | AGrant or award Pre-Funded Warrant (right to purchase)derivativeindirect: See footnote | +2,000,000 | - | - | 2,705,280 | Oct 22, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.